政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/145773
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文筆數/總筆數 : 113311/144292 (79%)
造訪人次 : 50940077      線上人數 : 948
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/145773


    題名: 探討醫藥學術部門在藥品行銷與藥廠價值鏈單元之定位與未來:以 B 公司特殊藥品為例
    Value Positioning and future of medical affair department in marketing and value chain of pharmaceutical industry: B company’s specialty medicine as example
    作者: 吳蕙如
    Wu, Hui-Ju
    貢獻者: 巫立宇
    吳蕙如
    Wu, Hui-Ju
    關鍵詞: 醫藥學術部門
    藥品行銷
    4C
    Medical affairs department
    Medicine promotion
    4C
    日期: 2023
    上傳時間: 2023-07-06 16:28:13 (UTC+8)
    摘要: 原開發性藥廠過去 15-20 年紛紛成立醫藥學術部門，目的在於提供客戶專業的科學訊息以及協助客戶能為病患治療做出最佳決策。醫藥學術部門為現今國際藥廠必要的組織，主要與最頂端或高專業度的客戶群交流合作。
    醫藥學術部門並不以業績為其績效指標，但卻在藥品行銷上扮演越來越重要的角色。醫藥學術部門是如何逐漸的改變，以傳統業務人員為主的客戶溝通模式，轉變為獨立且中立的科學討論模式。
    本論文欲探討以下議題：
    醫藥學術部門雖不以業績為其績效指標。在人力資源緊縮的時代，為什麼國
    際藥廠會日漸擴展醫藥學術部門的人力？
    以病患為中心是每個藥廠的核心理念，而Ｂ公司之醫藥學術部門在藥物價值
    鏈單元各扮演何角色？
    探討Ｂ公司之醫藥學術部門在行銷 4C 又扮演哪些角色？並且能創造出什麼價值？
    後疫情時代，Ｂ公司之醫藥學術部門是否應維持現有營運模式？或是否應朝
    向新型態、融合業務(sales representative) /醫藥學術專員(MSL, medical science liaison)為對外溝通模式？
    本論文的研究方法以訪談跨藥廠、跨部門之高階管理者，透過標準化的訪談
    大綱收集質性資料。再以描述性論述，交叉分析Ｂ公司之醫藥學術部門在藥品行銷之定位與未來。
    研究發現 B 公司醫藥學術部門，最大的優勢在於人才，基於員工過去
    多元職涯經驗能創造出更宏觀的策略並發揮價值。同時也發現 B 公司相較於其他公司在 C4 專屬陷入成本更有優勢，但如何透過跨部門整合，以及創造更多長期的專屬陷入成本之策略，會是 B 公司未來需思考的方向。訪談結果也提供了 B公司未來的改革方向，透過跨部門同質/異質培訓、強化外部客戶拜訪計畫、先驅計畫並漸進性改革，而將醫藥學術部門在藥品行銷 4C 之定位更明確，發揮更大的價值。
    Medical affair department had been established as a core organization of pharmaceutical companies in the past decades. The aim of establishing of medical affair team is to offer high quality of scientific information to clients and assist them to make optimal treatment decisions for patients. The core responsibility of medical affair is not driven by sales performance and it’s an independent role accompany life cycle of medicine commercialization. Moreover, medical affair transform the traditional promotional model of medicine, as it acts as independent, non-biased scientific communication model in the industry.
    There are objectives of this thesis,
    1) Why many international pharmaceutical companies expand the medical affair organization despite of human resources shortage recently?
    2) What is the core role and value of medical affair in medicine promotion in B company?
    3) Exploring the role & responsibility of medical affair in strategic marketing 4C (4 main cost) analysis? Which additional value been identified about medical affair
    team？
    Qualitative interview with executive managing leaders from different department in pharmaceutical companies, as the key sources for this research. According to standardized interview outline to collect all source information, crossover, description analysis as main methodology to explore the value positioning and the future direction
    of medical affairs in B company.
    Conclusion: talents is the most important advantage of medical affairs department of B company, particularly is C4. It would be the key consideration that how to integrate
    all resources cross-functionally to maximize the value of medical affairs department in C4 in the future. Moreover, those results also provide direction of revolution of B
    company by variable programs, such as tailor-made external communication plan, pilot project for future initiatives, in order to better value and positioning medical affairs in strategic marketing 4C in B company.
    參考文獻: 1. 邱志聖 (2020). 策略行銷分析－架構與實務應用，元照出版
    2. Javier C et al. (2022) The broadening role of medical affair- Learning from a MAPS 2022 global annual meeting panel. https://medicalaffairs.org/
    3. https://www.biogen.com/
    4. Biogen Financial Statements 2009-2023
    https://www.macrotrends.net/stocks/charts/BIIB/biogen/financial-statements
    描述: 碩士
    國立政治大學
    經營管理碩士學程(EMBA)
    110932156
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0110932156
    資料類型: thesis
    顯示於類別:[經營管理碩士學程EMBA] 學位論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    215601.pdf969KbAdobe PDF20檢視/開啟


    在政大典藏中所有的資料項目都受到原著作權保護.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋